Companies
Stay informed about the latest developments and news from cannabis companies with Business of Cannabis. Learn about new products, mergers and acquisitions, and more.
Companies · page 6
- M&A Activity
Curaleaf Completes Full Acquisition of Germany’s Four 20 Pharma
Curaleaf Holdings has completed the buyout of the remaining 45% stake in Four 20 Pharma GmbH, making the Paderborn-based medical cannabis producer and distributor a wholly owned subsidiary of the international cannabis giant.
- Pharmaceutical
German Distributor Fette Pharma Emerges From Restructuring Under New Investor Leadership
German medicinal cannabis distributor Fette Pharma GmbH has reported the successful completion of a strategic restructuring, almost seven months after an investor consortium led by entrepreneur Jörg Löser acquired the Egelsbach-based company in September 2025.
- Interviews
‘Thoughtful, Prudent, Patient’ – Why Village Farms Is Sitting Out the M&A Rush
The M&A scramble for Europe has continued at a fearsome pace over the last few weeks.
- M&A Activity
Has Rescheduling Accelerated the Cannabis M&A Wave?
Last week’s rescheduling announcement has placed a spotlight firmly on the medical cannabis arms of North America’s largest operators.
- Cultivation
‘More Cannabis Than Colombia’: How Jersey is Reshaping European Supply Chains
The Channel Island of Jersey supplied Germany’s medical cannabis market with more flower than Colombia last year, recent data shows.
- Cultivation
Agential Cannabis 2026 Takes Shape as APAC’s B2B Medicinal Cannabis Marketplace
International conference and focused expo set for 23–24 September 2026 at BITEC, Bangkok — with Austranna named Headline Sponsor Agential Cannabis 2026 will take place on 23–24 September 2026 at Bangkok International Trade & Exhibition Centre (BITEC), Bangkok, Thailand.
- Interviews
Bring It On: Meet the Cannabis CMO Welcoming Scrutiny With Open Arms
Scrutiny of the UK’s medical cannabis industry has rarely, if ever, been so acute since it was legalised in 2018.
- Cultivation
New Zealand’s Medical Cannabis Market Growth Slows as Major Operator Calls in Administrators
New Zealand’s medical cannabis market grew a further 25% in 2025, according to the latest official figures, seeing the country cement its position as one of the lesser-discussed but most exciting markets on the planet.
- Cultivation
De-Risking the Future: What’s Holding Traditional Industry Back from Cannabis Investment?
Nearly a decade after the inception of what we would now consider the ‘global cannabis industry’, Prohibition Partners forecasts its total worth to be around $40bn in 2025, already larger than the entire global recorded music industry.
- Cultivation
Business Brief: Canify and MG Health Announce Merger
German pharmaceutical cannabis company Canify AG and African medical cannabis cultivator MG Health Limited have announced a planned merger, marking yet another M&A deal in a market widely expected to see an incoming wave of consolidation.
- Industry Trends
Is the German Cannabis Boom Slowing Down, or Simply Normalising?
Germany’s cannabis imports, according to the latest figures from BfArM, nearly tripled in size in 2025, cementing it beyond any doubt as the engine behind Europe’s medical cannabis boom.
- Patient Access
Patient Protect Launches to Support UK Medical Cannabis Patients Facing Discrimination
A new UK-wide service supporting medical cannabis patients who face discrimination has launched, as the private sector continues to fill gaps left by the absence of systematic government support.
